Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval

British Journal of Clinical Pharmacology

Volumn 52, Issue 2, 2001, Pages 201-204

  Gillen, M S ^a   Miller, B ^a   Chaikin, P ^a   Morganroth, J ^a  

^a SANOFI   (France)

Author keywords

Ebastine; Electrocardiographic effects; Pharmacodynamics; QTc interval; Terfenadine

Indexed keywords

EBASTINE; TERFENADINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFECT; ELECTROCARDIOGRAM; HEART RATE; HUMAN; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; BUTYROPHENONES; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; HEART RATE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; PIPERIDINES; TERFENADINE;

EID: 0034826856     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01345.x     Document Type: Article

References (13)

1. Mechanisms of the cardiotoxic actions of terfenadine
2. Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability
3. Ebastine. An update of its use in allergic disorders
4. A review of the cardiac systemic side effects of antihistamines: Ebastine
5. Cardiac effects of ebastine and other antihistamines in humans
6. The electrocardiographic effects of cetirizine in normal subjects
7. An analysis of the time-relations of the electrocardiograms
8. Die systolendauer im elektrokardiogramm bei normalen menschen und bei herzkranken
9. Cardiac actions of antihistamines
10. Rate-corrected QT interval. Techniques and limitations
11. Rate correction of the QT interval
12. The prognostic value to the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens
13. Variability of the QTc interval: Impact on defining drug effect and low-frequency cardiac event